HHV8-Related Malignant Neoplasm — Trials

HHV8-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04577755	Pomalidomide Treatment in Patients With Kaposi Sarcoma	active not recruiting	Phase 2	45	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT02911142	Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma	active not recruiting	Phase 1 / Phase 2	17	National Cancer Institute (NCI)NIH	1	Aug 26, 2026	clinicaltrials